MDW commented on the Supreme Court of Canada hearing between GlaxoSmithKline Inc. v. The Queen regarding the arm’s length price for the active ingredient of a blockbuster drug and whether, or not, it should include the related intangibles.
MDW commented on the Supreme Court of Canada hearing between GlaxoSmithKline Inc. v. The Queen regarding the arm’s length price for the active ingredient of a blockbuster drug and whether, or not, it should include the related intangibles.